Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

JDOC vs. SHSSX: which is better?

Bottom line

JDOC vs SHSSX: the short answer

JDOC (JPMorgan Healthcare Leaders ETF) and SHSSX (Blackrock Health Sciences Opportunities Portfolio) share a meaningful slice of their top holdings — about 55% by weight.

But SHSSX is far broader, holding 155 positions to 61 for JDOC, so beyond the top names it adds exposure JDOC doesn't have.

JDOC is cheaper at 0.65% vs 0.86% — a difference of $21 a year per $10,000 invested.

Over one year, SHSSX returned +16.3% vs +14.9% for JDOC.

Updated Nov 19, 2026

JDOC vs SHSSX side by side

JDOCSHSSX
TypeETFMutual fund
Fund familyJ.P. MorganBlackRock
CategoryHealth Care SectorHealth Care Sector
Expense ratio0.65%0.86%
Annual cost per $10k$65$86
10-yr cost on $10k (prospectus)$810$1,061
Max front loadNone0%
12b-1 fee—0%
1-yr return+14.9%+16.3%
5-yr return (annualized)—+5.9%
10-yr return (annualized)—+9.8%
Best quarter+11.3%—
Worst quarter−11.9%—
Net assets (fund)$9.1M$5.9B
Number of holdings61155
Portfolio turnover92%49%
Returns as ofDec 31, 2025Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Holdings overlap

14 of JDOC's top 25 holdings also appear in SHSSX's top 25.

Shared top holdings
HoldingJDOCSHSSX
AbbVie, Inc.7.85%3.94%
Eli Lilly & Co.7.76%12.29%
UnitedHealth Group, Inc.5.85%6.10%
Merck & Co., Inc.4.82%4.94%
Johnson & Johnson4.82%8.77%
AstraZeneca plc3.76%1.21%
Thermo Fisher Scientific, Inc.3.73%3.02%
Abbott Laboratories3.11%1.97%
Stryker Corp.2.23%1.15%
Danaher Corp.2.16%2.00%
Intuitive Surgical, Inc.1.93%1.95%
Edwards Lifesciences Corp.1.73%2.51%
Regeneron Pharmaceuticals, Inc.1.60%0.91%
Biogen, Inc.1.56%1.21%

Source: SEC Form N-PORT

JDOC top 10

  1. AbbVie, Inc. — 7.85%
  2. Eli Lilly & Co. — 7.76%
  3. UnitedHealth Group, Inc. — 5.85%
  4. Merck & Co., Inc. — 4.82%
  5. Johnson & Johnson — 4.82%
  6. AstraZeneca plc — 3.76%
  7. Thermo Fisher Scientific, Inc. — 3.73%
  8. Bristol-Myers Squibb Co. — 3.57%
  9. Abbott Laboratories — 3.11%
  10. CVS Health Corp. — 2.83%

SHSSX top 10

  1. Eli Lilly & Company — 12.29%
  2. Johnson & Johnson — 8.77%
  3. Unitedhealth Group Inc — 6.10%
  4. Merck & Company Inc — 4.94%
  5. Gilead Sciences Inc — 4.19%
  6. Abbvie Inc — 3.94%
  7. Amgen Inc — 3.37%
  8. Thermo Fisher Scientific Inc — 3.02%
  9. Vertex Pharmaceuticals Inc — 2.74%
  10. Pfizer Inc — 2.61%

FAQ

What is the difference between JDOC and SHSSX?
JDOC (JPMorgan Healthcare Leaders ETF) and SHSSX (Blackrock Health Sciences Opportunities Portfolio) share a meaningful slice of their top holdings — about 55% by weight. But SHSSX is far broader, holding 155 positions to 61 for JDOC, so beyond the top names it adds exposure JDOC doesn't have.
Which is cheaper, JDOC or SHSSX?
JDOC has the lower expense ratio (0.65%).
Should I own both JDOC and SHSSX?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.